Showing 1,510 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Epidemiology

Other routes to HIV drug assistance

Editor's pick
Los Angeles Times
26 February 2011
Pharmaceutical industry

Drug R&D costs are less than estimated – so why the high prices?

Editor's pick
The Globe & Mail (Toronto)
25 February 2011
Pharmaceutical industry

Germany: Major fraud suspected with HIV drugs

Editor's pick
The Local
25 February 2011
Pharmaceutical industry

German authorities probe HIV drug fraud

Editor's pick
Bloomberg Business Week
24 February 2011
Pharmaceutical industry

Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV

Editor's pick
Xconomy
23 February 2011
Clinical trials

AIDS Activists Call on Public to Support New FDA HIV Drug Approval Policy

Editor's pick
Poz
23 February 2011
New & experimental HIV treatments

Chimerix Pockets $45M to Further Antiviral Development

Editor's pick
Genetic Engineering News
14 February 2011
New & experimental HIV treatments

Gilead refiles for approval of HIV drug

Editor's pick
San Francisco Business Times
11 February 2011
New & experimental HIV treatments

Sangamo's Bet Against AIDS: Gene Therapy

Editor's pick
Bloomberg Business Week
10 February 2011
Pharmaceutical industry

Big Pharma shows willingness to pool HIV/Aids drug patents

Editor's pick
The Guardian
10 February 2011
Pharmaceutical industry

Idenix drops after FDA loosens one hold but slaps on another

Editor's pick
Fierce Biotech
10 February 2011
Access to healthcare

South Carolina AIDS bill raises ire over generics requirement

Editor's pick
Myrtle Beach Sun News
10 February 2011
New & experimental HIV treatments

FDA Puts a Hold on Development of ViiV HIV Drug

Editor's pick
AIDSMeds
10 February 2011
Testing & health monitoring

OraSure 4th-quarter loss narrows on lower costs

Editor's pick
Bloomberg
10 February 2011
Pharmaceutical industry

Wikileaks: US Embassy Bangkok on Thai compulsory licenses for HIV drugs

Editor's pick
Thai Cables blog
9 February 2011
Pharmaceutical industry

Dollars for Docs Adds Payouts from HIV Drug Maker

Editor's pick
ProPublica
8 February 2011
Pharmaceutical industry

Are European Think Tanks Corporate Lobbyists By Another Name?

Editor's pick
Intellectual Property Watch
7 February 2011
Pharmaceutical industry

SOUTH AFRICA: Delayed Drug Registration Could Affect Region

Editor's pick
Inter Press Service
4 February 2011
Viral load

Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test

Editor's pick
PR Newswire
3 February 2011
Finance & funding

South Africa: Council Fails to Deliver Best ARV Combos

Editor's pick
AllAfrica
2 February 2011
Pharmaceutical industry

KEI comments on Tibotec voluntary licenses of a new HIV-AIDS product

Editor's pick
Knowledge Ecology International
29 January 2011
Pharmaceutical industry

Access to Medicines: Johnson & Johnson/Tibotec AIDS Drug Licenses Exclude Too Many Patients

Editor's pick
MSF
29 January 2011
New & experimental HIV treatments

J&J Generics Deal May Speed AIDS Drug Access in Africa, India

Editor's pick
Bloomberg Business Week
28 January 2011
HIV treatment

4Q Sales, Trends for Key Bristol-Myers Medicines

Editor's pick
Moreover.com HIV/AIDS feed
27 January 2011